Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Belgium
/
Healthcare
Create a narrative
Fagron
ENXTBR:FAGR Community
1
Narratives
written by author
0
Comments
on narratives written by author
5
Fair Values set
on narratives written by author
Create a narrative
Fagron
Popular
Undervalued
Overvalued
Fagron
WA
Analyst Price Target
Consensus Narrative from 5 Analysts
New Compounding Services Strategy Will Drive Customer Acquisition In North America
Key Takeaways Strategic acquisitions and improved commercial strategies are enhancing Fagron's market position, driving revenue growth, and expanding the product portfolio in key regions. Investments in operational excellence and a new facility will boost efficiency and profitability, while corrective actions ensure stability and investor confidence.
View narrative
€22.74
FV
16.6% undervalued
intrinsic discount
7.25%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
FAGR
Fagron
Your Fair Value
€
Current Price
€18.96
4.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-25m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue €1.2b
Earnings €110.9m
Advanced
Set as Fair Value